about
High levels of RNA-editing site conservation amongst 15 laboratory mouse strainsMouse genomic variation and its effect on phenotypes and gene regulationExpression profiling of repetitive elements by melting temperature analysis: variation in HERV-W gag expression across human individuals and tissuesMixture models for analysis of melting temperature data.A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientationGenetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism.The genomic landscape shaped by selection on transposable elements across 18 mouse strainsThe RNA-editing enzyme ADAR1 controls innate immune responses to RNA.Sequence-based characterization of structural variation in the mouse genome.Transcriptional derepression of the ERVWE1 locus following influenza A virus infectionRapid turnover of functional sequence in human and other genomes.Clinical and molecular consequences of disease-associated de novo mutations in SATB2.Influenza A virus transactivates the mouse envelope gene encoding syncytin B and its regulator, glial cells missing 1.Transactivation of elements in the human endogenous retrovirus W family by viral infection.Diagnostically relevant facial gestalt information from ordinary photos.Evaluation of minor groove binding probe and Taqman probe PCR assays: Influence of mismatches and template complexity on quantification.PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia.Molecular beacon-based temperature control and automated analyses for improved resolution of melting temperature analysis using SYBR I green chemistry.De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.Big data phenotyping in rare diseases: some ethical issues
P50
Q21184002-AE85A112-2BE2-45F3-81DF-4EC1C64D5753Q29617750-B898F0A2-2F01-47B5-B137-AD124561907DQ30887517-D14B5920-693F-413C-BA23-B338A150F201Q33368851-9AECE76A-C031-4EFD-B8ED-6C6374715334Q33791186-4A20E17E-8996-409D-AD03-FF6FF3BBC379Q34237629-C4DAA0DC-9C5E-4F72-83E0-473672550CE1Q34306542-3B23E848-EB60-49C1-9A0F-FCE11414137FQ35973393-A28C7CB8-2934-4B95-BB94-98789259231BQ36193488-F5FB1290-D1E5-4F28-832D-26D739036087Q37713897-3F9A236D-8948-455F-98E6-80DFF2FD1478Q37896644-5342ACB1-313A-4A73-9288-483309018192Q38984555-CDA7BCA0-35F1-416C-AA89-28883C4C87ACQ40141940-AB0E9CDC-9D39-4B07-A7FC-BE81603C6847Q40258726-9760246C-183D-4BF1-866B-874B1B2E079FQ41014879-4D04BEC5-8209-449C-AEDC-7C80B415F770Q43686690-9520D035-7D35-41AC-A016-0C74D978033EQ47386232-8775644C-448F-4582-8443-0FC29D1DBE91Q48141770-DB27811D-C48E-483E-97DA-0D11038B33A1Q50707803-3B37E443-790B-46C0-AF10-87B93B746D63Q54977264-6A7F63D4-6384-40FE-9DA5-0623BB0E9E3FQ58657465-996209FF-0858-49CF-A3C2-1BFF18EC1787
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christoffer Nellåker
@ast
Christoffer Nellåker
@en
Christoffer Nellåker
@es
Christoffer Nellåker
@nl
Christoffer Nellåker
@sl
type
label
Christoffer Nellåker
@ast
Christoffer Nellåker
@en
Christoffer Nellåker
@es
Christoffer Nellåker
@nl
Christoffer Nellåker
@sl
prefLabel
Christoffer Nellåker
@ast
Christoffer Nellåker
@en
Christoffer Nellåker
@es
Christoffer Nellåker
@nl
Christoffer Nellåker
@sl
P106
P21
P31
P496
0000-0002-2887-2068